Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors
- 1 September 2001
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (18) , 1416-1426
- https://doi.org/10.1038/sj.gt.3301549
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 45 references indexed in Scilit:
- Selective extraction of polyoma DNA from infected mouse cell culturesPublished by Elsevier ,2004
- Intratumoral Administration of Adenoviral Interleukin 7 Gene-Modified Dendritic Cells Augments Specific Antitumor Immunity and Achieves Tumor EradicationHuman Gene Therapy, 2000
- Cooperative Assembly of Androgen Receptor into a Nucleoprotein Complex That Regulates the Prostate-specific Antigen EnhancerJournal of Biological Chemistry, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Two Androgen Response Regions Cooperate in Steroid Hormone Regulated Activity of the Prostate-specific Antigen PromoterJournal of Biological Chemistry, 1996
- Prostate-specific Antigen Expression Is Regulated by an Upstream EnhancerJournal of Biological Chemistry, 1996
- Prostate Tissue Specificity of the Prostate-Specific Antigen Promoter Isolated from a Patient with Prostate CancerHuman Gene Therapy, 1995
- Human Renal Carcinoma Line Transfected With Interleukin-2 and/or Interferon Gene(s): Implications for Live Cancer VaccinesJNCI Journal of the National Cancer Institute, 1993
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Species‐ and organ‐specificity of secretory proteins derived from human prostate and seminal vesiclesThe Prostate, 1990